Back
Royalty Pharma Plc Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
RPRX
Royalty Pharma Plc
Last Price:
$44.81
Seasonality Move:
-3.3%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RPRX is experiencing slight buying pressure.
Royalty Pharma Plc Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.78 | Buy |
| 20-day SMA: | 41.66 | Buy |
| 50-day SMA: | 40.21 | Buy |
| 200-day SMA: | 36.97 | Buy |
| 8-day EMA: | 39.39 | Buy |
| 20-day EMA: | 25.97 | Buy |
| 50-day EMA: | 13.19 | Buy |
| 200-day EMA: | 3.75 | Buy |
Royalty Pharma Plc Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.26 | Buy |
| Relative Strength Index (14 RSI): | 73.48 | Buy |
| Chaikin Money Flow: | 1443781 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.69 - 43.17) | Buy |
| Bollinger Bands (100): | (36.6 - 41) | Buy |
Royalty Pharma Plc Technical Analysis
| Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Royalty Pharma Plc Stock
Is Royalty Pharma Plc Stock a Buy?
-
Royalty Pharma Plc share price is 44.25 while RPRX 8-day simple moving average is 43.78, which is a Buy signal.
-
The stock price of RPRX is 44.25 while Royalty Pharma Plc 20-day SMA is 41.66, which makes it a Buy.
-
Royalty Pharma Plc 50-day simple moving average is 40.21 while RPRX share price is 44.25, making it a Buy technically.
-
RPRX stock price is 44.25 and Royalty Pharma Plc 200-day simple moving average is 36.97, creating a Buy signal.
RPRX Technical Analysis vs Fundamental Analysis
Buy
52
Royalty Pharma Plc (RPRX)
is a Buy
Is Royalty Pharma Plc a Buy or a Sell?
-
Royalty Pharma Plc stock is rated a BuyThe current Royalty Pharma Plc [RPRX] share price is $44.25. The Score for RPRX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Royalty Pharma Plc Stock Info
Market Cap:
18.9B
Price in USD:
44.25
Share Volume:
5.2M
Royalty Pharma Plc 52-Week Range
52-Week High:
45.24
52-Week Low:
29.66
Buy
52
Royalty Pharma Plc (RPRX)
is a Buy
Royalty Pharma Plc Share Price Forecast
-
What is the Royalty Pharma Plc stock price today?The Royalty Pharma Plc stock price is 44.25 USD today.
-
Will RPRX stock go up or go down?Royalty Pharma Plc> share price is forecast to RISE/FALL based on technical indicators
-
Is Royalty Pharma Plc overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Royalty Pharma Plc is not overvalued.
Is Royalty Pharma Plc Stock a Buy?
-
Royalty Pharma Plc share price is 44.25 while RPRX 8-day exponential moving average is 39.39, which is a Buy signal.
-
The stock price of RPRX is 44.25 while Royalty Pharma Plc 20-day EMA is 25.97, which makes it a Buy.
-
Royalty Pharma Plc 50-day exponential moving average is 13.19 while RPRX share price is 44.25, making it a Buy technically.
-
RPRX stock price is 44.25 and Royalty Pharma Plc 200-day simple moving average is 3.75, creating a Buy signal.
Fundamental Analysis of Royalty Pharma Plc
Is Royalty Pharma Plc a good investment?
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.52 per share.
Technical Analysis of Royalty Pharma Plc
Should I short Royalty Pharma Plc stock?
-
RPRX Moving Average Covergence Divergence (MACD) indicator is 12.26, suggesting Royalty Pharma Plc is a Buy
-
Royalty Pharma Plc Relative Strength Index (RSI) is 73.48, which suggest Royalty Pharma Plc is overbought
-
The Bollinger Bands (25) for Royalty Pharma Plc is (39.69 - 43.17), which suggest Royalty Pharma Plc is a Buy
-
The Bollinger Bands (100) for Royalty Pharma Plc is (36.6 - 41), which suggest Royalty Pharma Plc is a Buy
* Royalty Pharma Plc stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.